|
Supplementary Protection Certificate (SPC) Summary of Applications |
|||
| SPC No. | 2010/016 | ||
|---|---|---|---|
| Date of filing | 14/04/2010 | ||
| Notification of Application Published | 26/05/2010 | ||
| Status | Withdrawn | ||
| Notification of Grant Published | |||
| Date of Expiry of SPC | |||
| Applicant |
NOVARTIS AG Lichstrasse 35 4056 Basel SWITZERLAND |
||
| Patent Number | 71155 | ||
| Title of Invention | Acyl compounds | ||
| Date of Expiry of Patent | 17/02/2011 | ||
| Product Type | Medicinal Product | ||
| Product Identity | Valsartan, amlodipine and hydrochlorothiazide and pharmaceutically acceptable salt thereof | Market Authorisation | Ireland | Switzerland |
| Authorisation No | EU/1/09/569/001-060 | 59407 | |
| Authorisation Date | 16/10/2009 | 16/09/2009 | |
| Identity of Product Authorised | EXFORGE HCT | Exforge HCT | |
| Address for Service |
TOMKINS & CO. 5 Dartmouth Road Dublin 6 IRELAND |
||
| Renewal Fees | |||
| 29/04/2010 | Request for grant a Supplementary Protection Certificate filed on 14/04/2010, numbered 2010/016. | ||
| 14/03/2012 | Request for grant of Supplementary Protection Certificate No. 2010/016 withdrawn on 13/03/2012. [Journal No. 2200, 11/04/2012] | ||